CONTEXT/ BACKGROUND: Research has shown that problem gambling (PG) is associated with substance use disorders (SUD) and also with other mental disorders (MD). Nevertheless, evidence about the relative contribution of each type of disorder for the risk of gambling in the population is very limited. OBJECTIVE: Study the association of SUD, alone and in combination with MD, with the prevalence and severity of PG. DESIGN: Cross-sectional national survey (Canadian Community Health Survey-Mental Health and Well-Being) data collected through a multi-stage stratified cluster design. SETTING: Population-based household survey. PARTICIPANTS: This analysis includes data on 36 885 participants (99.7% of the survey sample). MAIN OUTCOME MEASURES: The prevalence and severity of PG were measured using the Canadian Problem Gambling Index. Prevalence of MD (mood and anxiety disorders) and SUD were defined according to the World Mental Health Survey Initiative Composite International Diagnostic Interview, following definitions of the DSM-IV. RESULTS: Compared to the population, higher prevalence rates of PG are observed when the severity of SUD is higher, but are not impacted by the co-occurrence of MD. For individuals with low risk and moderate risk/problem gambling, the prevalence rate difference (prevalence rate in the subgroup minus prevalence rate in the population) observed among substance dependents was reduced when MD co-occurred (from a prevalence rate difference of 2.5; 99% confidence interval 1.6-3.8 to 1.6; 99% confidence interval 1.2-2.2 for low risk gamblers and from 3.7; 99% confidence interval 1.6-5.5 to 2.9; 99% confidence interval 2.0-4.3 for moderate risk/problem gamblers). Estimates were not statistically different. CONCLUSIONS: Prevalence of all levels of PG increased with SUD severity, but the pattern did not appear to be affected by MD co-occurrence. Results suggest particular attention be given to SUD in treatment-seeking clients with co-occurring disorders.
CONTEXT/ BACKGROUND: Research has shown that problem gambling (PG) is associated with substance use disorders (SUD) and also with other mental disorders (MD). Nevertheless, evidence about the relative contribution of each type of disorder for the risk of gambling in the population is very limited. OBJECTIVE: Study the association of SUD, alone and in combination with MD, with the prevalence and severity of PG. DESIGN: Cross-sectional national survey (Canadian Community Health Survey-Mental Health and Well-Being) data collected through a multi-stage stratified cluster design. SETTING: Population-based household survey. PARTICIPANTS: This analysis includes data on 36 885 participants (99.7% of the survey sample). MAIN OUTCOME MEASURES: The prevalence and severity of PG were measured using the Canadian Problem Gambling Index. Prevalence of MD (mood and anxiety disorders) and SUD were defined according to the World Mental Health Survey Initiative Composite International Diagnostic Interview, following definitions of the DSM-IV. RESULTS: Compared to the population, higher prevalence rates of PG are observed when the severity of SUD is higher, but are not impacted by the co-occurrence of MD. For individuals with low risk and moderate risk/problem gambling, the prevalence rate difference (prevalence rate in the subgroup minus prevalence rate in the population) observed among substance dependents was reduced when MD co-occurred (from a prevalence rate difference of 2.5; 99% confidence interval 1.6-3.8 to 1.6; 99% confidence interval 1.2-2.2 for low risk gamblers and from 3.7; 99% confidence interval 1.6-5.5 to 2.9; 99% confidence interval 2.0-4.3 for moderate risk/problem gamblers). Estimates were not statistically different. CONCLUSIONS: Prevalence of all levels of PG increased with SUD severity, but the pattern did not appear to be affected by MD co-occurrence. Results suggest particular attention be given to SUD in treatment-seeking clients with co-occurring disorders.
Authors: Susana Jiménez-Murcia; Roser Granero; Salomé Tárrega; Ariadna Angulo; Fernando Fernández-Aranda; Jon Arcelus; Ana B Fagundo; Neus Aymamí; Laura Moragas; Anne Sauvaget; Marie Grall-Bronnec; Mónica Gómez-Peña; José M Menchón Journal: J Gambl Stud Date: 2016-03
Authors: Lior Rennert; Cécile Denis; Kyle Peer; Kevin G Lynch; Joel Gelernter; Henry R Kranzler Journal: Exp Clin Psychopharmacol Date: 2014-02 Impact factor: 3.157